LSAK vs TECH · rev $659.7M vs P/E 65, rev $1.22B
Lesaka Technologies Inc (LSAK) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Lesaka Technologies Inc (LSAK) is a software - infrastructure company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LSAK revenue for 2025-06-30 was $659.7M. Net income was -$87.6M. Revenue was up 16.9% from 2024-06-30 to 2025-06-30. LSAK currently screens at market cap $433.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LSAK currently screens at market cap $433.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LSAK and TECH stock pages for the full models.
Not investment advice.